Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction

References

• Axelsson L, Bergenfeldt M, Ohlsson K. (1995). Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest 55:577–88
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Bennett M, Haase M, et al. (2010). Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 36:452–61
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Uchino S, Bellomo R, et al. (2007). Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2:431–9
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, et al. (2001). Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, et al. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–55
   PubMed Web of Science ®Google Scholar
• Borregaard N, Cowland JB. (1997). Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503–21
   PubMed Web of Science ®Google Scholar
• Cai L, Borowiec J, Xu S, et al. (2009). Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances. Clin Chim Acta 403:121–5
   PubMed Web of Science ®Google Scholar
• Cai L, Rubin J, Han W, et al. (2010). The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 5:2229–35
   PubMed Web of Science ®Google Scholar
• Calandra T, Cohen J. (2005). The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538–48
   PubMed Web of Science ®Google Scholar
• Constantin JM, Futier E, Perbet S, et al. (2010). Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 25:176 e1–6
   Web of Science ®Google Scholar
• Cruz DN, de Cal M, Garzotto F, et al. (2010). Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36:444–51
   PubMed Web of Science ®Google Scholar
• de Geus HR, Bakker J, Lesaffre EM, le Noble JL. (2011). Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 183:907–14
   PubMed Web of Science ®Google Scholar
• Fjaertoft G, Foucard T, Xu S, Venge P. (2005). Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. Acta Paediatr 94:661–6
   PubMed Web of Science ®Google Scholar
• Flo TH, Smith KD, Sato S, et al. (2004). Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917–21
   PubMed Web of Science ®Google Scholar
• Grigoryev DN, Liu M, Hassoun HT, et al. (2008). The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 19:547–58
   PubMed Web of Science ®Google Scholar
• Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. (1993). Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425–32
   PubMed Web of Science ®Google Scholar
• Klausen P, Niemann CU, Cowland JB, et al. (2005). On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur J Haematol 75:332–40
   PubMed Web of Science ®Google Scholar
• Kumpers P, Hafer C, Lukasz A, et al. (2010). Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 14:R9 . doi:10.1186/cc8861
   PubMed Web of Science ®Google Scholar
• Kuwabara T, Mori K, Mukoyama M, et al. (2009). Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 75:285–94
   PubMed Web of Science ®Google Scholar
• Linscheid P, Seboek D, Nylen ES, et al. (2003). In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144:5578–84
   PubMed Web of Science ®Google Scholar
• Linscheid P, Seboek D, Schaer DJ, et al. (2004). Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715–21
   PubMed Web of Science ®Google Scholar
• Martensson J, Bell M, Oldner A, et al. (2010). Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333–40
   PubMed Web of Science ®Google Scholar
• Martensson J, Xu S, Bell M, et al. (2012). Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 413:1661–7
   PubMed Web of Science ®Google Scholar
• Meisner M, Lohs T, Huettemann E, et al. (2001). The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18:79–87
   PubMed Web of Science ®Google Scholar
• Meisner M, Schmidt J, Huttner H, Tschaikowsky K. (2000). The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 26:S212–16
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, et al. (2005). Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–8
   PubMed Web of Science ®Google Scholar
• Perry TE, Muehlschlegel JD, Liu KY, et al. (2010). Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg 110:1541–7
   PubMed Web of Science ®Google Scholar
• Prabhu A, Sujatha DI, Ninan B, Vijayalakshmi MA. (2010). Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann Vasc Surg 24:525–31
   PubMed Web of Science ®Google Scholar
• Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, et al. (2007). Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18:407–13
   PubMed Web of Science ®Google Scholar
• Tang BM, Eslick GD, Craig JC, McLean AS. (2007). Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7:210–17
   PubMed Web of Science ®Google Scholar
• Uchino S, Kellum JA, Bellomo R, Doig GS, et al. (2005). Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813–18
   PubMed Web of Science ®Google Scholar
• Uzzan B, Cohen R, Nicolas P, et al. (2006). Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996–2003
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Sprung CL, et al. (2006). Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–53
   PubMed Web of Science ®Google Scholar
• Xu SY, Pauksen K, Venge P. (1995). Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 55:125–31
   PubMed Web of Science ®Google Scholar
• Xu SY, Carlson M, Engstrom A, et al. (1994a). Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest 54:365–76
   PubMed Web of Science ®Google Scholar
• Xu SY, Petersson CG, Carlson M, Venge P. (1994b). The development of an assay for human neutrophil lipocalin (HNL)–to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 171:245–52
   PubMed Web of Science ®Google Scholar